Breast Cancer Proteomics and Molecular Heterogeneity
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
Primary objective: The primary objective is to define the proteomic and molecular characteristics of primary and recurrent/ metastatic breast tumours with special focus on the expression of S100 protein and the estrogen receptor (ER), progesterone receptor (PR) and epidermal growth factor receptor 2 (HER2) genes Secondary objective: * To expand our understanding of the complex molecular pathways dictating the progression of breast cancer and their response to different treatment regimes. * To relate proteomic findings to survival data * To identify potential serum markers of breast cancer progression
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci z nowotworem piersi przychodzą do szpitala na operację usunięcia guza
- •Pacjenci z podejrzeniem lub potwierdzonym nowotworem piersi nawracającym lub przerzutami, którzy przychodzą do szpitala na operację, biopsję lub leczenie
- •Pacjenci z podejrzeniem zaawansowanego nowotworu piersi (stadium 4) przychodzą do szpitala na operację, biopsję lub leczenie
- •Pacjenci mogą przyjmować leczenie przedoperacyjne
- •Wiek co najmniej 18 lat
- •Pacjent musi być w stanie wyrazić świadomą zgodę na udział w badaniu
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- December 19, 2025
- Sex
- Female only
Locations (6)
Cork University Hospital
Cork, Ireland
Beaumont Hospital
Dublin, Ireland
St James's Hospital
Dublin, Ireland
St. Vincent's University Hospital
Dublin, Ireland
University Hospital Limerick
Limerick, Ireland
University Hospital Waterford
Waterford, Ireland
Trial contact
Cancer Trials Ireland
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.